KBY Biotech Indexv0.0.34
Search
← Pipeline|Tiracagene

Tiracagene

Phase 3
CDT-5606
By Cidara Therapeutics
Source: Trial-derived·Trials: 1
Modality
mAb
MOA
RAS(ON)i
Target
SOS1
Pathway
Innate Imm
RSVSCDTTR Amyloidosis
Development Pipeline
Preclinical
~Oct 2014
→ ~Jan 2016
Phase 1
~Apr 2016
→ ~Jul 2017
Phase 2
~Oct 2017
→ ~Jan 2019
Phase 3
Apr 2019
→ Dec 2025
Phase 3Current
NCT08351066
1,956 pts·RSV
2019-04→2025-12·Not yet recruiting
1,956 total pts1 indication
NDA/BLA
Approved
CompletedCurrentUpcoming
Catalysts (1)
2025-12-233mo agoPh3 Readout· RSV
Trial Timeline
Q2Q3Q42020Q2Q3Q42021Q2Q3Q42022Q2Q3Q42023Q2Q3Q42024Q2Q3Q42025Q2Q3Q4
P3
Not yet…
Catalysts
Ph3 Readout
2025-12-23 · 3mo ago
RSV
Not yet recruiting|StartCompletionToday
Trials (1)
NCTPhaseIndicationStatusNEP
NCT08351066Phase 3RSVNot yet recr...1956HbA1c
Competitors (10)
DrugCompanyPhaseTargetMOA
MRK-6781Merck & CoApprovedTIGITRAS(ON)i
TerarelsinAbbViePreclinicalSOS1SOS1i
RibofutibatinibAstraZenecaPhase 2/3SOS1PCSK9i
SNY-9073SanofiPhase 2B7-H3RAS(ON)i
VoxacageneGilead SciencesPhase 2/3SOS1TYK2i
TixarelsinVertex PharmaPhase 1ALKRAS(ON)i
SRP-9822SareptaPhase 3SOS1FGFRi
FixatuximabLegend BiotechPreclinicalCFTRRAS(ON)i
ION-1378IonisNDA/BLATROP-2RAS(ON)i
180-3597Innovent BioPreclinicalSHP2RAS(ON)i